scispace - formally typeset
Y

Yi Yan Yang

Researcher at Agency for Science, Technology and Research

Publications -  374
Citations -  22011

Yi Yan Yang is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Micelle & Antimicrobial. The author has an hindex of 75, co-authored 358 publications receiving 19328 citations. Previous affiliations of Yi Yan Yang include National University of Singapore & Imperial College London.

Papers
More filters
Journal ArticleDOI

Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy

Majad Khan, +4 more
- 01 Jul 2012 - 
TL;DR: Key advances in drug and gene delivery are summarized with focus on the development of polymers, peptides, liposomes and inorganic materials as nanocarriers for co‐delivery of small molecular drugs and macromolecular genes or proteins.
Journal ArticleDOI

Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions.

Xuan Jiang, +5 more
- 01 Apr 2006 - 
TL;DR: This study has examined the possibility of using polyethylene glycol (PEG)‐grafted chitosan/DNA complexes to deliver genes to the liver through bile duct and portal vein infusions.
Journal ArticleDOI

Thermosensitive Poly(N-isopropylacrylamide-co-acrylic acid) Hydrogels with Expanded Network Structures and Improved Oscillating Swelling−Deswelling Properties

† Xian-Zheng Zhang, +3 more
- 21 Feb 2002 - 
TL;DR: In this article, a P(NIPAAm-co-AAc) hydrogel with rapid temperature sensitivity and improved oscillatory properties over small temperature cycles around the physiologic temperature of 37 °C was synthesized.
Journal ArticleDOI

Synthetic hydrogels for controlled stem cell differentiation

Shaoqiong Liu, +5 more
- 01 Jan 2010 - 
TL;DR: Recent advances in the synthesis and modification of PEG hydrogels will be presented, along with important physicochemical considerations in the design of these hydrogel to better mimic the stem cell microenvironment and direct stem cell differentiation.
Journal ArticleDOI

Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.

Pei Yun Teo, +9 more
- 01 Jun 2015 - 
TL;DR: These findings are the first to demonstrate that PD‐L1 knockdown in EOC cells, via siRNA/FA‐targeted delivery, are able to sensitize cancer cells to T cell killing.